What is the appropriate management approach for a 43-year-old woman who had heavy menstrual bleeding in her last cycle, is currently not bleeding, has normal vital signs, and transvaginal ultrasound shows a bulky uterus with coarse myometrium suggestive of adenomyosis and a few fibroids?

Management Approach for 43-Year-Old Woman with Heavy Menstrual Bleeding, Adenomyosis, and Fibroids

For this 43-year-old woman with combined adenomyosis and fibroids presenting with heavy menstrual bleeding, initiate medical management as first-line therapy, with the levonorgestrel-releasing intrauterine system (LNG-IUS) being the most effective option, followed by combined hormonal contraceptives or tranexamic acid if the LNG-IUS is not suitable. 1

Initial Assessment and Workup

Before initiating treatment, complete the following essential evaluations:

• Check hemoglobin/hematocrit to assess for anemia from the heavy bleeding
• Verify the patient is not currently pregnant (pregnancy test if any doubt)
• Assess fertility desires explicitly - this fundamentally changes the treatment algorithm
• Quantify bleeding severity using pictorial blood loss assessment chart (PBAC) if available 2
• Rule out endometrial pathology - at age 43 with heavy bleeding, consider endometrial sampling if risk factors present (obesity, anovulation, unopposed estrogen exposure) 3

The transvaginal ultrasound has already been performed and shows the dual pathology, which is common and affects treatment selection.

Medical Management Algorithm (First-Line)

Most Effective Option: LNG-IUS (20 μg/24 hours)

• Reduces menstrual blood loss by 71-95% in women with adenomyosis and fibroids 4
• Works for both adenomyosis and fibroid-related bleeding
• Can be inserted once current bleeding episode resolves and hemoglobin is adequate
• Critical caveat: This is a long-term maintenance therapy, not for acute bleeding control 5

Alternative Medical Options (in descending order of effectiveness):

1. Combined hormonal contraceptives (oral or vaginal ring) - second-line choice 1
2. Tranexamic acid (1-1.5g three times daily during menses) - effective non-hormonal option 1, 6
3. Long-course oral progestogens (≥21 days per cycle, such as norethindrone 5-10mg daily) 1, 4

Short-Term Preoperative Medical Options:

If planning future procedural intervention:

• GnRH agonists (leuprolide) or GnRH antagonists (relugolix with add-back estrogen/progestin) reduce fibroid volume and bleeding 1
• Use for 3-6 months maximum before surgery
• Require add-back hormonal therapy to prevent bone loss and hypoestrogenic symptoms 1

When Medical Management Fails or Is Inappropriate

If Patient Desires Uterus Preservation:

Uterine Artery Embolization (UAE) is the preferred minimally invasive option for combined adenomyosis and fibroids 1:

• Prospective studies show 94% short-term and 85% long-term symptom improvement 1
• Particularly effective when fibroids predominate over adenomyosis 1
• Only 7-18% require subsequent hysterectomy for persistent symptoms 1
• Lower reintervention rates compared to MR-guided focused ultrasound 1
• Important counseling point: Pregnancy is possible after UAE, though comprehensive fertility data is limited 1

If Patient Has Completed Childbearing:

Hysterectomy provides definitive resolution of all symptoms 1:

• Most effective for combined adenomyosis and fibroids
• Choose least invasive route: vaginal > laparoscopic > abdominal 1
• Critical consideration at age 43: Preserve ovaries to avoid premature menopause and associated cardiovascular risks 1
• Be aware hysterectomy carries risks: increased cardiovascular disease, mood disorders, and when performed young, potentially increased mortality 1

Common Pitfalls to Avoid

1. Don't use endometrial ablation - it has high failure rates with adenomyosis present 1
2. Don't delay anemia treatment - start iron supplementation immediately if hemoglobin is low
3. Don't assume all bleeding is from fibroids/adenomyosis - at age 43, endometrial pathology must be excluded, especially if she has risk factors 3
4. Don't insert LNG-IUS during active heavy bleeding - wait until bleeding controlled and anemia corrected 5
5. Don't use short-course progestogens (≤14 days/cycle) - they are minimally effective for heavy bleeding 1, 4

Practical Treatment Pathway

Step 1: If currently not bleeding and hemodynamically stable (as stated):

• Check hemoglobin, start iron if anemic
• Discuss fertility desires
• Consider endometrial sampling if risk factors present

Step 2: Initiate medical management:

• First choice: LNG-IUS insertion (schedule when convenient, patient is not bleeding)
• If LNG-IUS declined/contraindicated: Combined hormonal contraceptives or tranexamic acid during menses

Step 3: If medical management fails after 3-6 months:

• Desires uterus preservation: UAE
• Completed childbearing: Hysterectomy (least invasive route, preserve ovaries)

Step 4: If UAE fails (occurs in 7-18% of cases):

• Proceed to hysterectomy

This stepwise approach prioritizes quality of life through symptom control while minimizing morbidity from invasive procedures, which is particularly important given the patient's relatively young age and the chronic nature of both conditions 1.